Orthomolecular Solutions to Heart Disease

The following simple solution to prevent heart disease is currently ignored in favour of
paradigm of more invasive and lucrative disease management. Studying the the data below,
one could conclude that the eradication of the this disease has been known for some time but
is simply being ignored. This is an update to a note I sent to a number of people who wanted
to know about some inexpensive non drug solutions. This note is by no means complete as I
have not covered herbal and other mineral adjuncts. So far - 5 people. that I know, have tired
vitamin C and Lysine and have had very good results.

Chris Gupta

This type of empowered and cost effective disease prevention is becoming a real threat to the
medical industry thus the CODEX initiative. Again, at the risk of boring the reader, I direct
you to the following link and encourage you to educate as many people as possible on this
imminent loss of safe health solutions and our freedoms.
http://www.iahf.com/anh_lawsuit.html

1) Linus Pauling Therapy for Heart Disease is at http://www.paulingtherapy.com/ and

copiously describes a non toxic, cost effective Orthomolecular approach using vitamin C and
amino acids Lysine and Proline.

16] According to the Pauling/Rath 1994 United States patent, the amino acid lysine (lysine
analogs), along with vitamin C and other antioxidants (e.g. Co-Q10, vitamin E and vitamin
A), can, in sufficient concentration, inhibit Lp(a) binding to exposed lysine residues. Proline
residues are also exposed by lesions in blood vessels. Later experiments showed that proline
as well as lysine, with vitamin C, other amino acids and antioxidants, in oral amounts well
past what is needed for prevention, becomes a solvent by inhibiting the binding of Lp(a). A
binding inhibitor augmented with vitamin C can stop and apparently even reverses some
plaque formations. Pauling and Rath even have a second U. S. patent for using these binding
inhibitors as solvents to melt atherosclerotic plaques from human organs during organ
transplants. The organ is dipped in the Lp(a) Binding Inhibitor solution and the plaques melt
away.

U. S. Patent # 5,278,189 is for the prevention and treatment of occlusive cardiovascular

disease with vitamin C and substances that inhibit the binding of lipoprotein-(a).

See also patent 5,230,996 .

Backing this up with Vitamin B6 is described in the Joe Hattersley paper "Vitamin B6: The
overlooked Key to preventing heart attacks" More supporting data in response to my earlier
email also has been included at the end of this note

ABSTRACT: Vitamin B6 (pyridoxine) opens the door to eliminating the 20th century's
epidemic of heart attacks, cardiac arrests and strokes. Although shunned by the researchers
who receive the bulk of heart disease research funding, it is creating excitement among a
growing number of investigators. In this article relevant bits of B6's history are presented to
show how it can prevent heart attacks with almost no side effects from moderate amounts.
This article will also integrate the effects of vitamin B6 deficiency with Mathias Rath and
Linus Pauling's theory (blaming heart attacks on deficient vitamin C and excess Lp(a) and
Bruce Lipton's histamine theory into a general theory of atherogenesis.

Vitamin B6 The overlooked Key to preventing heart attacks.PDF

As usual any effective products such as amino acids (mentioned below) which are very
effective for many diseases and essentially non toxic (far less toxic than even salt) are
banned illegally by Health Canada to protect their pharmaceutical friends! So you will
have get them from the states - 250 (500 mg) tablets of lysine are available for approx $5
from US Walmart stores. The underground cost in Canada is over $50 courtesy of
Health Canada.

Chris Gupta

See also:

Reduction of Lipoprotein(a) in Postmenopausal Women

As a general surgeon who is interested in the prevention of postmenopausal heart disease and
in particular in the reduction of lipoprotein(a) [Lp(a)], I read with great interest the recent
review by Dr Mosca1 regarding the role of HRT. Rapid progression of arteriographically
determined coronary artery disease has been significantly more common in subjects with
Lp(a) levels higher than 25 mg/dL.2 Approximately 33% of the population have elevated
levels of Lp(a) (>25 mg/dL), a condition that is an independent risk factor for coronary artery
disease.3, 4 The treatment currently recommended for postmenopausal women with Lp(a)
levels higher than 25 mg/dL consists of a combination of HRT and niacin.4 The adverse
effects of niacin use are flushing, headache, and liver dysfunction. I am a 53-year-old woman
with a significantly elevated level of Lp(a) (27 mg/dL), but I found that I had to stop taking
niacin primarily because of headaches. Thus, after a thorough review of the literature, I began
to follow the advice of Linus Pauling. For individuals who have an Lp(a) level higher than 25
mg/dL and a family history of heart disease, the recommendation is to take 3 g/d of both
ascorbic acid and L-lysine monohydrochloride.5 After 6 months of this regimen, with no
adverse effects, my Lp(a) level decreased to 14 mg/dL, a reduction of 48%. The Lp(a) testing
was done by the highly reliable Lawrence Berkeley National Laboratory/Berkeley HeartLab
Department Technology Transfer program. The theory is that lysine is an Lp(a)-binding
inhibitor and thus blocks the Lp(a) attachment to the arterial blood vessel wall and that
ascorbic acid helps to repair the collagen injury to the blood vessel and acts as an
antioxidant.5-7 Currently, pilot studies are being conducted on the Pauling therapy of elevated
levels of Lp(a).

Kathie M. Dalessandri, MS, MD

Point Reyes Station, Calif

1. Mosca L. The role of hormone replacement therapy in the prevention of postmenopausal

heart disease. Arch Intern Med. 2000;60:2263-2272.
2. Terres W, Tatsis E, Pfalzer B, Beil FU, Beisiegel U, Hamm CW. Rapid angiographic
progression of coronary artery disease in patients with elevated lipoprotein(a). Circulation.
1995;91:948-950. MEDLINE

3. Bostom AG, Cupples LA, Jenner JL, et al. Elevated plasma lipoprotein(a) and coronary
heart disease in men aged 55 years and younger: a prospective study. JAMA. 1996;276:544-
548. MEDLINE

4. Superko HR. Did grandma give you heart disease? the new battle against coronary artery
disease. Am J Cardiol. 1998;82:34Q-46Q. MEDLINE

5. Pauling L, Rath M. Solution to the puzzle of human cardiovascular disease: its primary
cause is ascorbate deficiency leading to the deposition of lipoprotein(a) and fibrinogen/fibrin
in the vascular wall. J Orthomol Med. 1992;6:125-133.

6. Rath M, Pauling L. Hypothesis: lipoprotein(a) is a surrogate for ascorbate. Proc Natl Acad
Sci U S A. 1990;87:6204-6207. MEDLINE

7. Pauling L. The Last Interview [videotape]. Lisle, Ill: Intellisoft Multimedia Inc; 1994.

(Arch Intern Med. March 12, 2001;161:772-773,)

Reduction of Lipoprotein(a) in Postmenopausal Women

http://www.paulingtherapy.com/AMAPostMenapause.html

In response to the above Joe wrote

From: JosephHattersley@aol.com
Date: Fri, 30 May 2003 13:18:52 EDT
Subject: Re: Orthomolecular Solutions to Heart Disease

Good work, Chris. On vitamin B6 why not add the info from trials:

(1) Thousands of people in East Texas took 50-300 milligrams of B6 daily for many years
under the guidance of John Marion Ellis, MD, of Mt. Pleasant, Texas. He urged no change in
the lives of patients suffering from carpal tunnel syndrome and osteoarthritis -- those
symptoms accurately portray high cardiac risk -- except "Take vitamin B6." Yet a
retrospective study found his patients had 73 percent fewer chest pains and heart attacks than
thousands of ab-stainers in the same area; they lived seven to 17 years longer; and they felt
better. Ellis JM, McCully KS. Prevention of myocardial infarction by vitamin B6. Research
Comm Molec Path and Pharmacol 1995; 89; 2:208-220.

(They -- and patients of Moses M. Suzman, MD, using B6 from 1950-1990 -- never
complained of over publicized neurological side effects. A few people may be sensitive to this
vitamin as pyridoxine hydrochloride, its common supplemented form. Russell Jaffe, MD,
PhD, eliminated neurological side effects among thousands of volunteers by using
pharmaceutical grade B6, 200 to 2,000 milligrams daily for up to two years. Lecture in
Seattle, 1990. The product is available from VRP 1-800-877-2447; 1-702-884-1300
www.vrp.com, and possibly from others.)
(2) Among a sample of women followed for 20 years in the prospective Nurses' Health Study,
after adjustment for other risk factors heart attack risk dropped 17 percent for each two-
milligram increase in daily B6 consumption in both diet and supplements. Higher intakes
yielded lower cardiac risk; an increase of eight milligrams might then lower risk by 68%.
Rimm EB, Willett WC et al. Folate and vitamin B6 from diet and supplements in relation to
risk of coronary heart disease among women. Journal American Medical Assoc. 1998; 279;
5:359-364.

(3) In the 10-year ARIC (Atherosclerosis Risk in Communities) study, the people in the
highest quintile of plasma vitamin B6 had 72 percent fewer heart attacks than those in the
lowest quintile of plasma B6. As in Dr. Ellis's experience, for non-cardiac patients nothing but
B6 made any difference in cardiac risk - not even now-famous homocysteine. Folsom AR,
Nieto FJ et al. Prospective study of coronary heart disease incidence in relation to fasting total
homo-cysteine, related genetic polymorphisms, and B vitamins. Circulation 1998; 98:204-
210.

Moses M. Suzman, MD, of Johannesburg, South Africa, earlier confirmed that finding with
tens of thousands of patients over a period of forty years but did not publish the results.
Hattersley JG. Acquired atherosclerosis: Theories of causation, novel therapies. Jour
Orthomolecular Med 1991; 6:83-98. Derived from 50 telephone conversations and a 3-day
stay at Dr. Suzman's home in Johannesburg, April 1992, with several interviews.

The findings appear to confirm all the requirements for proof that vitamin B6 prevents heart
attacks. Doll, Sir Richard. Proof of causality. Deduction from epidemiological observation.
Perspectives Biol Med 2002; 45; 4: 499-515
.
Cordially, Joe

See also:

Bad News About Statin Drugs

Stop America's # 1 Killer!...Heart Disease

Class Action - Statins Increases Heart Disease By 10% In Women

Re: Artery Cleansers And Heart Disease

FAQ about Cholesterol & Heart Disease

Vitamin E: Safe, Effective, and Heart-Healthy

Vitamins Prevent Heart Disease

Dark Chocolate is Good for Your Heart

Heart Failure Drug That Saves Lives Can Be Fatal

Cholesterol Does Not Cause Coronary Heart

Heart Disease and Copper

Magnesium Chloride In Acute And Chronic Diseases

posted by Chris Gupta on Tuesday June 3 2003

updated on Thursday October 5 2006

Print this article

TrackBack

Related Articles
Artificial Water Fluoridation: Off To A Poor Start / Fluoride Injures The Newborn
Please watch this short 5 minute video: Little Things Matter: The Impact of Toxins on the
Developing Brain Toxins such as Arsenic, Lead, Mercury, Aluminum and other known and
unknown chemicals, that are often above the legal limits, are deliberately added to our water
to manage the disposal of toxic industrial waste chemicals under the pretense of "safe and
effective" for water fluoridation mantra.Knowing and acting on the above should... [read
more]
December 30, 2014 - Chris Gupta

Drinking Water Fluoridation is Genotoxic & Teratogenic

This paper by Prof. Joe Cummins is a very important 5 minute delegation made to London
Ontario Canada "Civic Works Committee" public participation meeting on January 25, 2012
on fluoride*. While a bit technical it is short and easy to grasp. A must read as it goes to the
heart of the matter regarding the well established toxicity of fluoride which is well in all
scientific circles even before water... [read more]
February 06, 2012 - Chris Gupta

Democracy At Work? - PPM On Fluoride

Here is a commentary on the recent (Jan, 25th, 2011) Public Participation Meeting (PPM) on
Fluoride in the City of London, Ontario. The meeting started with a strong pro fluoride stance
form the City engineer. His lack of knowledge on chemistry of the toxic wastes used to
fluoridate water could embarrass even a high school student never mind his own profession.
He blatantly violated his "duty to public welfare" as... [read more]
January 29, 2012 - Chris Gupta

Readers' Comments

Can I read more of your independent essay on this alternative therapy on heart problem.Iam
hypertensive with an enlarged heart from X-ray result .I do receive relieve when I take vit.C
not as a therapy, and it agrees with your presentation.Please, advise.

Thanks.

Isika,Martins.PhD.

Posted by: Dr Isika, M.A. on September 29, 2004 09:28 PM

I need more information on heart problem remedy. Iam also hypertensive with enlarged heart
from recent X-ray result .

Assist.

Thanks.
Isika Martins.
Posted by: Isika Martins on September 29, 2004 09:56 PM

Isika, read the following:

Lysine and The Pauling Therapy

For Hypertension see:

POTASSIUM DEFICIENCY SCAM KILLS AND MAIMS MILLIONS

Deliberately restricting your potassium intake makes you very ill, and
thus vulnerable to hundreds of highly profitable medical "cures"

Posted by: Chris Gupta on September 30, 2004 07:33 PM

Cardioretinometry:

Posted by: Sydney Bush PhD., DOpt. (IOSc. London) on October 22, 2004 11:59 PM

Well, my echo with doppler showed minor damage upper left (oxygenated air return) chamger
of my heart with some valve leakage. And the pulmonary function showed only slightly over
2 liter lung capacity and the test was set to show 3 as normal!
So, since I have been taking 10mg Maxalt for 3 years now, some months only 4-6 and some
months 6-8. The warnings on the Maxalt indicate possible heart damage where no damage
existed before; does anyone have any documentated heart damage from Maxalt? Its new for
this kind of documentation, but would appreciate any info available. Do not understand the
loss of lung power, test diagnosis same as "ideopathic".

Posted by: kate sisco on June 13, 2005 04:01 PM

In my opinion the simple most solution is that we should be excercising daily walks early in
the morning.

Posted by: Kane on December 30, 2005 05:35 AM

To repeat my earlier comment, I am confident that cardioretinometry will prove to be a better
surrogate outcome predictor of coronary arterial health than electron beam tomography or
angiography with none of the problems of cost, safety and invasiveness. Nutritional
prophylactic cardioretinometry should save many lives and improve the lives of many more.

Posted by: Jeremy on November 29, 2006 04:21 AM

Can co Q10 help prevent heart attacks and stroke?

Posted by: adam on June 8, 2007 01:55 PM